Proton magnetic resonance spectroscopy in brain white matter disorders

Neurological Sciences

Volumn 18, Issue 6, 1997, Pages 331-339

  De Stefane, N ^a,b   Federico, A ^a   Arnold, D L ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Leukodystrophy; Magnetic resonance; Multiple sclerosis; Spectroscopy; White matter

Indexed keywords

PROTON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN DISEASE; BRAIN ISCHEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKOENCEPHALOPATHY; METABOLISM; METHODOLOGY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BRAIN DISEASES; BRAIN ISCHEMIA; HIV-1; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS; PROTONS;

EID: 0031299544     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. ARNOLD DL, MATTHEWS PM, FRANCIS G, ANTEL J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease, Magn. Reson. Med., 1990; 14: 154-159.
2. ARNOLD DL, MATTHEWS PM, FRANCIS OS, O'CONNOR J, ANTEL JP. Proton Magnetic Resonance Spectroscopic Imaging for Metabolic Characterization of Demyelinating Plaques. Ann, Neural., 1992; 31: 235-241.
3. ARNOLD DL, MATTHEWS PM, DE STEFANO N. MRI and proton MRS in the evaluation of multiple sclerosis. In: Bachelard, eds. Magnetic resonance spectroscopy and imaging in neurochemistry. New York: Plenum Press. 1997; 8: 267-288.
4. ARNOLD DL, MATTHEWS PM. Clinical applications of brain magnetic resonance spectroscopy. In: IR Young, C Charles, eds. MR Spectroscopy: Clinical Applications and Techniques. London: Martin Dunitz. 1995.
5. AUSTIN SJ, CONNELLY A, GADIAN DG, BENTON JS, BRETT EM. Localized 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn. Reson. Med., 1991; 19: 439-445.
6. BARDOSI A, CREUTZFELDT W, DIMAURO S, et al. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-coxidase. A new mitochondrial multisystem disorder. Acta Neuropathol, 1987; 74: 248-258.
7. BARNES D, MUNRO PMG, YOUL BD, PRINEAS JW, McDoNALD WI. The longstanding MS lesion; aquantitative MRI and electron microscopic study. Brain, 1991; 114: 1271-1280.
8. BRUHN H, KRUSE B, KORENKE GC, et al. Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr, 1992; 16: 335-344.
9. BURGEOIS M. GOUTIERES F, CHRETIEN D, RUSTIN P, MUNNICH A, AICARDI J. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev., 1992; 14: 404-408.
10. CHANG L, ERNST T, TORNATORE C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology, 1997; 48: 836-845.
11. CHONG WK, SWEENEY B, WILKINSON ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology, 1993; 188: 119-124.
12. CONSTANTS JM, MEYERHOFF DJ, NORMAN D, et al. H-1 and P-31 magnetic resonance spectroscopic imaging of white matter signal hypeintensity areas in elderly subjects. Neuroradiology, 1995; 37: 615-623.
13. DAVIE CA, HAWKINS CP, BARKER GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain, 1994; 117: 49-58.
14. DE STEFANO N, GENGE A, KARPATI G, MATTHEWS PM, ARNOLD DL. Improvement of cerebral metabolism in patients with mitochondrial disorders by Dichloroacetate (DCA) treatment. Neurology, 1995a; 45: 1193-1198.
15. DE STEFANO N, MATTHEWS PM, ANTEL JP, PREUL M,FRANCIS G, ARNOLD DL. Chemical-pathology of acute demyelinating lesion and its correlation with disabilitv. Ann, Neural., 1995b; 38: 901-909.
16. DE STEFANO N, MATTHEWS PM, FEDERICO A, ARNOLD DL. Brain N-acetylaspartate as an index of central nervous svstem impairment in brain white matter disorders. Eur J. Neurol., 1996; 3: 64.
17. DE STEFANO N, MATTHEWS PM, NARAYANAN S, FRANCIS OS, ANTEL JP, ARNOLD DL. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology, 1997; In Press.
18. DE STEFANO N, MATTHEWS PM, ARNOLD DL. Reversible decreases in N-acetvlaspartate following acute brain injury. Mag Res Med, 1995; 34: 721-727.
19. FEDERICO A. Classification of leukodvstrophies. Mol. Chem. Neuropathol, 1996; 27: 3-4.
20. FERGUSON B, MATYSZAK MK, ESIRI MM, PERRY VH. Axonal damage in acute multiple sclerosis lesions. Brain, 1997; 120: 393-399.
21. HACHINSKI VC, POTTER P, MERSKEY H. Leuko-araiosis. Arch. Neurol, 1987; 44: 21-23.
22. HANEFELD F, HOLZBACH U, KRUSE B, WILICHOWSKI E, CHRISTEN HJ, FRAHM J. Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics, 1993; 24: 244-248.
23. HUSTED CA, GOODIN DS, HUGG JW, et al. Biochemical alterations in multiple sclerosis lesions and normalappearing white matter detected by in vivo 3IP and IH spectroscopic imaging. Ann. Neurol., 1994; 36: 157-165.
24. JOHANNIK K, VAN HECKE P, FRANCOIS B, et al. Localized brain proton NMR spectroscopv in voung adult pheiniketonuria patients. Magn. Reson. Med., 1994; 31: 53-57.
25. KOLODNY EH. Dysmyelinating and demyelinating conditions in infancy. [ReviewJ. Curr. Opin. Neurol. Neurosurg.. 1993; 6: 379-386.
26. KOOPMANS RA, Li DK, ZHU G, ALLEN PS, PENN A. PATY DW. Magnetic resonance spectroscopv of multiple sclerosis: in-vivo detection of mvelin breakdown products /letterJ. Lancet, 1993; 341: 631-632.
27. KRUSE B. HANEFELD F, CHRISTEN HJ. et al. Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopv in vivo. J. Neurol., 1993; 241: 68-74.
28. KRUSE B, BARKER PB, VAN ZUL PC, DUYN JH. MOONEN CT, MOSER HW. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodvstrophy. Ann. Neurol., 1994; 36: 595-608.
29. LEUTNER C, LAYER G, ZIERZ S, SOLYMOSI L, DEWES W, REISER M. Cerebral MR in ophthalmoplegia plus. Ajnr: Am. J. Neuroradiol., 1994; 15: 681-687.
30. MACKAY S, MEYERHOFF DJ, CONSTANTS JM, NORMAN D, FEIN G. WEINER MW. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with IH magnetic resonance spectroscopic imaging. Arch. Neurol., 1996; 53: 167-174.
31. MARKS HG, CARO PA, WANG ZY, et al. Use of computed tomographv, magnetic resonance imaging, and localized IH magnetic resonance spectroscopv in Canavan's disease: a case report. Ann. Neurol., 1991; 30: 106-110.
32. MATTHEWS PM, ALLAIRE C, SHOUBRIDGE EA, KARPATI G, CARPENTER S, ARNOLD DL. In vivo muscle magnetic resonance spectroscopv in the clinical investigation of mitochondria! disease. Neurology, 1991; 41: 114-120.
33. MATTHEWS PM, FRANCIS G, ANTEL J, ARNOLD DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis[published erratum appears in Neurology 1991 Nov;41(l 1 ):1828]. Neurology, 1991; 41: 1251-1256.
34. MATTHEWS PM, ANDERMANN F, SILVER K, KARPATI G, ARNOLD DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomy apathies. Neurology, 1993; 43: 2484-2490.
35. MCDONALD WI. Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis. [Review], J. Neuropathol. Exp. Neurol., 1994; 53: 338-343.
36. MENON DK, BAUDOUIN CJ, TOMLINSON D, HOYLE C. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J. Comput. Assist. Tomogr., 1990; 14: 882-885.
37. MEYER JS, KAWAMURA J, TERAYAMA Y. White matter lesions in the elderly. [Review]. J. Neurol. Sci., 1992; 110: 1-7.
38. MILLER DH, ALBERT PS, BARKHOF F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann. Neurol., 1996a; 39:6-16.
39. MILLER DH, ALBERT PS, BARKHOF F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol, 1996b; 39: 6-16.
40. MOFFETT JR, NAMBOODIRI MAA, CANORO CB, NEALE JH. Immunohistochemical localization of N-acetylaspartate in rat brain. NeuroReport, 1991; 2: 131-134.
41. NAKAI A, GOTO Y, FUJISAWA K, et al. Diffuse leukod\strophy with a large-scale mitochondrial DMA deletion. Lancet, 1994; 343: 1397-1398.
42. [421 NARAYANAN S, Fu L, PIORO E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann. Neurol., 1997; 41:385-391.
43. PETROFF OA, GRAHAM GD, BLAMIRE AM, et al. Spectroscopic imaging of stroke in humans: histopathology correlates of spectral changes. Neurology, 1992; 42: 1349-1354.
44. PRINEAS JW. CONNELL F. The fine structure of chronically active multiple sclerosis plaques. Neurology, 1978; 28 (Suppl.2): 68-75.
45. RAINE CS, CROSS AH. Axonal dystrophy as a consequence of long-term dennelination. Lab. Invest., 1989; 60: 714-725.
46. RODRIGUEZ M, SCHEITHAUER B. Ultrastructure of multiple sclerosis. Ultrastruct. Pathol., 1994; 18: 3-13.
47. SCHMIDT R, HAYN M, FAZEKAS F, KAPELLER P, ESTERBAUER H. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturallv occurring antioxidants. Stroke, 1996; 27: 2043-2047.
48. SIMMONS ML, FRONDOZA CO, COYLE JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience, 1991; 45: 37-45.
49. SMITH RR, HENDRIE HC. Leuko-araiosis: description and clinical correlates. Compr. Ther., 1992; 18: 7-16.
50. STRANDGAARD S, PAULSON OB. Cerebrovascular damage in hvpertension. [Review]. J. Cardiovasc. Risk, 1995; 2: 34-39.
51. TEDESCHI G, SCHIFFMANN R, BARTON NW, et al. Proton magnetic resonance spectroscopy imaging in childhood ataxia with diffuse central nervous system hypomvelination. Neurology, 1995; 45: 1526-1532.
52. TZIKA'AA, BALL WS, JR, VIGNERON DB, DUNN RS, NELSON SJ, KIRKS DR. Childhood adrenoleukodystrophy:assessment with proton MR spectroscopv. Radiology, 1993; 189:467-480.
53. VAN DER KNAAP MS, VALK J, DE NEELING N, NAUTA JJ. Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology, 1991; 33: 478-493.
54. VAN DER KNAAP MS, VAN DER GROND J, LUYTEN PR, DEN HOLLANDER JA, NAUTA JJP, VALK J. 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann Neurol, 1992; 31: 202-211.
55. VAN DER KNAAP MS, BARTH PG, STROINK H, et al. Leukoencephalopathy with swelling and a discrepantly mild clinical course in eight children. Ann. Neurol., 1995a; 37: 324-334.
56. VAN DER KNAAP MS, VALK J, BARTH PG, SMIT LM, VAN ENGELEN BG. TORTORI DONATI P. Leukoencephalapatliy with swelling in children and adolescents: MRI patterns and differential diagnosis. Neuroradiology, 1995b; 37: 679-686.
57. VAN DER KNAAP MS, VALK I. Progress in MR pattern recognition of unclassified white matter disorders. Riv. Neuroradiol., 1996; 9: 789-794.
58. VION-DURY J. NICOLI F, SALVAN AM, et al. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy [letter]. Lancet. 1995; 345: 60-61.
59. WILKINSON ID. MILLER RF, MISZKIEL KA, et al. Cerebral proton magnetic resonance spectroscopv in asymptomatic HIV infection. AIDS, 1997; 11: 289-295.